Review



densitometry analysis software alphalmager  (Alpha Innotech)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Alpha Innotech densitometry analysis software alphalmager
    (a) Hsp70 levels are not altered in parkin-deficient AR-JP brains. Equivalent detergent-soluble and -insoluble protein fractions extracted from frontal cortex tissue of control (1–4) and parkin-deficient AR-JP brains (1–4) were analyzed by Western blot with anti-Hsp70 antibody, or anti-actin antibody as a protein loading control. Hsp70 levels were quantified by <t>densitometry</t> and normalized to β-actin levels in the detergent-soluble and -insoluble fraction of control (n = 4) and AR-JP (n = 4) brains. Data are expressed as a percentage (%) of control levels as the ratio of Hsp70 to β-actin, and bars represent the mean ± SEM. (b) Hsp70 displays reduced detergent-solubility in sporadic PD/DLB brains. Equivalent detergent-soluble and -insoluble protein fractions extracted from cin-gulate cortex tissue of control (5–6), Alzheimer’s disease (AD; 1–2) and PD/DLB (1–5) brains, were analyzed by Western blot with anti-Hsp70 antibody, or with anti-SOD1 and anti-β-tubulin antibodies as protein loading controls. Hsp70 levels were quantified by densitometry and normalized in the detergent-soluble and -insoluble fraction of control (control + AD; n = 4) and PD/DLB (n = 5) brains. Data are expressed as a percentage (%) of control levels as the ratio of Hsp70 to SOD1 (soluble) or β-tubulin (insoluble), and bars represent the mean ± SEM. Differences between means were analyzed by two-tailed unpaired Student’s t-test, *p < 0.05 when compared with control, ns, non-significant.
    Densitometry Analysis Software Alphalmager, supplied by Alpha Innotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/densitometry analysis software alphalmager/product/Alpha Innotech
    Average 90 stars, based on 1 article reviews
    densitometry analysis software alphalmager - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Parkin mediates the degradation-independent ubiquitination of Hsp70"

    Article Title: Parkin mediates the degradation-independent ubiquitination of Hsp70

    Journal: Journal of neurochemistry

    doi: 10.1111/j.1471-4159.2008.05261.x

    (a) Hsp70 levels are not altered in parkin-deficient AR-JP brains. Equivalent detergent-soluble and -insoluble protein fractions extracted from frontal cortex tissue of control (1–4) and parkin-deficient AR-JP brains (1–4) were analyzed by Western blot with anti-Hsp70 antibody, or anti-actin antibody as a protein loading control. Hsp70 levels were quantified by densitometry and normalized to β-actin levels in the detergent-soluble and -insoluble fraction of control (n = 4) and AR-JP (n = 4) brains. Data are expressed as a percentage (%) of control levels as the ratio of Hsp70 to β-actin, and bars represent the mean ± SEM. (b) Hsp70 displays reduced detergent-solubility in sporadic PD/DLB brains. Equivalent detergent-soluble and -insoluble protein fractions extracted from cin-gulate cortex tissue of control (5–6), Alzheimer’s disease (AD; 1–2) and PD/DLB (1–5) brains, were analyzed by Western blot with anti-Hsp70 antibody, or with anti-SOD1 and anti-β-tubulin antibodies as protein loading controls. Hsp70 levels were quantified by densitometry and normalized in the detergent-soluble and -insoluble fraction of control (control + AD; n = 4) and PD/DLB (n = 5) brains. Data are expressed as a percentage (%) of control levels as the ratio of Hsp70 to SOD1 (soluble) or β-tubulin (insoluble), and bars represent the mean ± SEM. Differences between means were analyzed by two-tailed unpaired Student’s t-test, *p < 0.05 when compared with control, ns, non-significant.
    Figure Legend Snippet: (a) Hsp70 levels are not altered in parkin-deficient AR-JP brains. Equivalent detergent-soluble and -insoluble protein fractions extracted from frontal cortex tissue of control (1–4) and parkin-deficient AR-JP brains (1–4) were analyzed by Western blot with anti-Hsp70 antibody, or anti-actin antibody as a protein loading control. Hsp70 levels were quantified by densitometry and normalized to β-actin levels in the detergent-soluble and -insoluble fraction of control (n = 4) and AR-JP (n = 4) brains. Data are expressed as a percentage (%) of control levels as the ratio of Hsp70 to β-actin, and bars represent the mean ± SEM. (b) Hsp70 displays reduced detergent-solubility in sporadic PD/DLB brains. Equivalent detergent-soluble and -insoluble protein fractions extracted from cin-gulate cortex tissue of control (5–6), Alzheimer’s disease (AD; 1–2) and PD/DLB (1–5) brains, were analyzed by Western blot with anti-Hsp70 antibody, or with anti-SOD1 and anti-β-tubulin antibodies as protein loading controls. Hsp70 levels were quantified by densitometry and normalized in the detergent-soluble and -insoluble fraction of control (control + AD; n = 4) and PD/DLB (n = 5) brains. Data are expressed as a percentage (%) of control levels as the ratio of Hsp70 to SOD1 (soluble) or β-tubulin (insoluble), and bars represent the mean ± SEM. Differences between means were analyzed by two-tailed unpaired Student’s t-test, *p < 0.05 when compared with control, ns, non-significant.

    Techniques Used: Control, Western Blot, Solubility, Two Tailed Test



    Similar Products

    densitometry analysis software alphalmager  (Alpha Innotech)
    90
    Alpha Innotech densitometry analysis software alphalmager
    (a) Hsp70 levels are not altered in parkin-deficient AR-JP brains. Equivalent detergent-soluble and -insoluble protein fractions extracted from frontal cortex tissue of control (1–4) and parkin-deficient AR-JP brains (1–4) were analyzed by Western blot with anti-Hsp70 antibody, or anti-actin antibody as a protein loading control. Hsp70 levels were quantified by <t>densitometry</t> and normalized to β-actin levels in the detergent-soluble and -insoluble fraction of control (n = 4) and AR-JP (n = 4) brains. Data are expressed as a percentage (%) of control levels as the ratio of Hsp70 to β-actin, and bars represent the mean ± SEM. (b) Hsp70 displays reduced detergent-solubility in sporadic PD/DLB brains. Equivalent detergent-soluble and -insoluble protein fractions extracted from cin-gulate cortex tissue of control (5–6), Alzheimer’s disease (AD; 1–2) and PD/DLB (1–5) brains, were analyzed by Western blot with anti-Hsp70 antibody, or with anti-SOD1 and anti-β-tubulin antibodies as protein loading controls. Hsp70 levels were quantified by densitometry and normalized in the detergent-soluble and -insoluble fraction of control (control + AD; n = 4) and PD/DLB (n = 5) brains. Data are expressed as a percentage (%) of control levels as the ratio of Hsp70 to SOD1 (soluble) or β-tubulin (insoluble), and bars represent the mean ± SEM. Differences between means were analyzed by two-tailed unpaired Student’s t-test, *p < 0.05 when compared with control, ns, non-significant.
    Densitometry Analysis Software Alphalmager, supplied by Alpha Innotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/densitometry analysis software alphalmager/product/Alpha Innotech
    Average 90 stars, based on 1 article reviews
    densitometry analysis software alphalmager - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (a) Hsp70 levels are not altered in parkin-deficient AR-JP brains. Equivalent detergent-soluble and -insoluble protein fractions extracted from frontal cortex tissue of control (1–4) and parkin-deficient AR-JP brains (1–4) were analyzed by Western blot with anti-Hsp70 antibody, or anti-actin antibody as a protein loading control. Hsp70 levels were quantified by densitometry and normalized to β-actin levels in the detergent-soluble and -insoluble fraction of control (n = 4) and AR-JP (n = 4) brains. Data are expressed as a percentage (%) of control levels as the ratio of Hsp70 to β-actin, and bars represent the mean ± SEM. (b) Hsp70 displays reduced detergent-solubility in sporadic PD/DLB brains. Equivalent detergent-soluble and -insoluble protein fractions extracted from cin-gulate cortex tissue of control (5–6), Alzheimer’s disease (AD; 1–2) and PD/DLB (1–5) brains, were analyzed by Western blot with anti-Hsp70 antibody, or with anti-SOD1 and anti-β-tubulin antibodies as protein loading controls. Hsp70 levels were quantified by densitometry and normalized in the detergent-soluble and -insoluble fraction of control (control + AD; n = 4) and PD/DLB (n = 5) brains. Data are expressed as a percentage (%) of control levels as the ratio of Hsp70 to SOD1 (soluble) or β-tubulin (insoluble), and bars represent the mean ± SEM. Differences between means were analyzed by two-tailed unpaired Student’s t-test, *p < 0.05 when compared with control, ns, non-significant.

    Journal: Journal of neurochemistry

    Article Title: Parkin mediates the degradation-independent ubiquitination of Hsp70

    doi: 10.1111/j.1471-4159.2008.05261.x

    Figure Lengend Snippet: (a) Hsp70 levels are not altered in parkin-deficient AR-JP brains. Equivalent detergent-soluble and -insoluble protein fractions extracted from frontal cortex tissue of control (1–4) and parkin-deficient AR-JP brains (1–4) were analyzed by Western blot with anti-Hsp70 antibody, or anti-actin antibody as a protein loading control. Hsp70 levels were quantified by densitometry and normalized to β-actin levels in the detergent-soluble and -insoluble fraction of control (n = 4) and AR-JP (n = 4) brains. Data are expressed as a percentage (%) of control levels as the ratio of Hsp70 to β-actin, and bars represent the mean ± SEM. (b) Hsp70 displays reduced detergent-solubility in sporadic PD/DLB brains. Equivalent detergent-soluble and -insoluble protein fractions extracted from cin-gulate cortex tissue of control (5–6), Alzheimer’s disease (AD; 1–2) and PD/DLB (1–5) brains, were analyzed by Western blot with anti-Hsp70 antibody, or with anti-SOD1 and anti-β-tubulin antibodies as protein loading controls. Hsp70 levels were quantified by densitometry and normalized in the detergent-soluble and -insoluble fraction of control (control + AD; n = 4) and PD/DLB (n = 5) brains. Data are expressed as a percentage (%) of control levels as the ratio of Hsp70 to SOD1 (soluble) or β-tubulin (insoluble), and bars represent the mean ± SEM. Differences between means were analyzed by two-tailed unpaired Student’s t-test, *p < 0.05 when compared with control, ns, non-significant.

    Article Snippet: Quantitation of protein levels was performed using densitometry analysis software (Alphalmager, Alpha Innotech Corp.) and data were analyzed by two-tailed unpaired Student’s t -test to determine differences between the means.

    Techniques: Control, Western Blot, Solubility, Two Tailed Test